iShares US Pharmaceuticals ETF (IHE) closed at $101.06 on October 16, 2026, down 0.1% from the previous close, on volume of 211,125 shares (30-day average 217,856).
Data as of October 16, 2026.
No press releases found.
Mentions of inflation have ballooned for tech companies – SoFi
Seeking Alpha News (Tue, 13-Oct 2:18 PM ET)
Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q3
Seeking Alpha News (Tue, 13-Oct 9:35 AM ET)
Healthcare, biotech, pharma are key diversifiers as AI disrupts digital economy – UBS
Seeking Alpha News (Mon, 12-Oct 1:00 PM ET)
The iShares Dow Jones U.S. Pharmaceuticals Index Fund seeks investment results that correspond generally to the price and yield performance before fees and expenses of the Dow Jones U.S. Select Pharmaceuticals Index.
iShares US Pharmaceuticals ETF trades on the ARCA stock market under the symbol IHE.
As of October 16, 2026, IHE stock price declined to $101.06 with 211,125 million shares trading.
IHE has a beta of 0.15, meaning it tends to be less sensitive to market movements. IHE has a correlation of 0.01 to the broad based SPY ETF.
IHE has a market cap of $1.54 billion. This is considered a Small Cap stock.
In the last 3 years, IHE traded as high as $108.66 and as low as $55.36.
IHE has outperformed the market in the last year with a price return of +37.9% while the SPY ETF gained +15.9%. IHE has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +2.4% and +2.1%, respectively, while the SPY returned +1.4% and -0.1%, respectively.
IHE support price is $99.73 and resistance is $102.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IHE shares will trade within this expected range on the day.
